I agree, I hope there is a shareholder presentation or a release of a status report which outlines/‘closes off‘
*status of JATPHARM - expected volumes, what products available, outlook for the coming year/future outlook
*status of the production facility - expected volumes, what products will be produced, future outlook, outline of distribution channels
*closure on previous announcements which have not matured as intended, the shop in China, the GK contract, how healthone are going
*intentions for the AUS domestic market even if not entering until a future year (i.e. 2025), how the office is set to expand, employment of a domestic communication person
*CIIE expectations and products (even though JAR JAR already found them, it would be good for the broader sharemarket to see)
*expectations for the year to come
*outline of the corporate structure and aspirations moving forward (I.e looking to establish a head of marketing)
and there are are probably things I’ve missed...
Of the things I have written above, I’m not expecting a major announcement anymore like a new deal etc, basically I want a document (business plan/shareholder presentation or something similar) that states JAT isn’t what it was, it is travelling in a new direction and has articulated this clearly to the AUS market.
Expand
